title: Rosuvastatin restores advanced glycation end product-induced decrease in sirtuin 1 (SIRT1) mRNA levels in THP-1 monocytic cells through its anti-oxidative properties.
authors.forename: Yuji
authors.initials: Y
authors.lastname: Ishibashi
authors.forename: Sae
authors.initials: S
authors.lastname: Nakashima
authors.forename: Takanori
authors.initials: T
authors.lastname: Matsui
authors.forename: Sho-ichi
authors.initials: S
authors.lastname: Yamagishi
mesh_terms: D000818:Animals; D000975:Antioxidants / Q000494:pharmacology*; D002417:Cattle; D045744:Cell Line, Tumor; D005464:Fluorobenzenes / Q000494:pharmacology*; D017127:Glycation End Products, Advanced / Q000633:toxicity*; D006801:Humans; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism*; D011743:Pyrimidines / Q000494:pharmacology*; D012333:RNA, Messenger / Q000378:metabolism*; D000068718:Rosuvastatin Calcium; D056564:Sirtuin 1 / Q000378:metabolism*; D013449:Sulfonamides / Q000494:pharmacology*
chemical_list: D000975:Antioxidants; D005464:Fluorobenzenes; D017127:Glycation End Products, Advanced; D011743:Pyrimidines; D012333:RNA, Messenger; D013449:Sulfonamides; D000068718:Rosuvastatin Calcium; C447939:SIRT1 protein, human; D056564:Sirtuin 1